State bills · Business & Consumers
What's moving in state legislatures -- introductions, committee action, floor votes and sponsors.
Filter bills
-
SB 852 — Missouri
Prohibits the use of credit scores in determining automobile insurance rates
SB 852 - This act provides that, for all automobile insurance contracts entered into on or after August 28, 2026, no insurer shall utilize any information obtained directly or indirectly from a consumer reporting agency or any insurance credit score that relies on information obtained directly or indirectly from a consumer reporting agency for the purpose of determining the rate charged for such contract. This act is identical to HB 2632 (2026). TAYLOR MIDDLETON
-
SB 921 — Missouri
Creates new provisions relating to digital forms of identification
SB 921 - This act prohibits public entities from requiring any person to obtain or maintain any digital form of identification, as that term is defined in the act. The use of a digital form of identification may be offered by a public entity as an option when interacting with any person, but the person cannot be required to obtain or use a digital form of identification unless a physical form of identification is offered as an alternative in lieu of the digital form of identification. The use of a digital form of identification may also be offered by a private entity as an option when interacting with any person. A person who has agreed to use a digital form of identification shall be permitted, upon request, to view, correct, destroy, or restrict the usage of all personal data associated with the person's own identification. A person who has authorized the usage of any personal data associated with the person's digital form of identification for one purpose shall not be deemed authorization for any other purpose. Personal data of any person may only be collected for the purpose stated by the public or private entity and only upon the consent of each individual person, or in the case of a minor, only upon consent of a parent of the minor. Personal data of any person shall not be sold or transferred to any public or private entity without the consent of the person. A public entity shall not, with respect to any individual person, take any action or refuse to take any action based solely on the personal data of a person. Furthermore, a digital form of identification shall not be required by a public entity to enter any place of public accommodation. Any person may bring a cause of action in a court of competent jurisdiction if the person alleges that a public entity has violated this act. A public entity found by a court to have violated this act shall be liable to the person affected for not more than $150,000 per occurrence. This act shall not be construed to prohibit any public entity from complying with any lawful request from a law enforcement agency with respect to any person's personal data. The act additionally provides that no person shall be required to obtain a mobile driver's license. Furthermore, a person's driver's license shall not be linked with any automated license plate reader without the written consent of such person. TAYLOR MIDDLETON
-
SB 930 — Missouri
Creates provisions relating to anesthesia services
SB 930 - Under this act, no health carrier or health benefit plan shall establish, implement, or enforce any policy that imposes a time limit for the payment of anesthesia services provided during a medical or surgical procedure, as described in the act. This provision is identical to provisions in HCS/SB 94 (2025), HCS/HBs 1126 & 932 (2025), and SCS/HCS/HB 94 (2025), and similar to provisions contained in SCS/SB 841 (2026), HB 2570 (2026), the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), HCS/HBs 1945 & 2570, and HB 1944 (2026). TAYLOR MIDDLETON
-
SB 846 — Missouri
Enacts provisions relating to insurance coverage of health care services
SB 846 - This act enacts provisions relating to insurance coverage of pharmacy services. CLINICIAN-ADMINISTERED DRUGS (Section 376.411) This act provides that a health carrier or pharmacy benefits manager (PBM) shall not impose any penalty, impediment, differentiation, or limitation on participating providers for providing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to refusing to approve or pay, or reimbursing less than the contracted payment amount. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on a covered person who is administered medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to: limiting coverage or benefits; requiring an additional fee, higher co-payment, or higher coinsurance amount; or interfering with a patient's ability to obtain a clinician-administered drug from the patient's provider or pharmacy of choice by any means, including but not limited to inducing, steering, or offering financial or other incentives. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on any pharmacy that is dispensing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to requiring a pharmacy to dispense the drugs to a patient with the intention that the patient will transport the medication to a health care provider for administration. These provisions shall not apply if the clinician-administered drug is not otherwise covered by the carrier or PBM. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). REFERENCE PRODUCTS AND BIOSIMILARS (Section 376.415) A health carrier or PBM providing coverage for a reference product or a biological product that is biosimilar to the reference product shall provide coverage for the reference product and all biological products that have been deemed biosimilar to the reference product. The scope, extent, and amount of the required coverage shall be the same, including but not limited to any payment limitations or cost-sharing obligations. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). 340B DRUG PRICING PROGRAM (Section 376.416) Under this act, no health carrier or pharmacy benefits manager (PBM) shall discriminate against a covered entity or a pharmacy, as such terms are defined in the act, by: • Reimbursing a covered entity or pharmacy for a quantity of a 340B drug, as defined in the act, in an amount less than the carrier, PBM, or affiliate would pay to any other similarly situated pharmacy for such quantity of the drug on the basis that the entity or pharmacy is a covered entity or a pharmacy, or that the entity or pharmacy dispenses 340B drugs. (Section 376.416.2(1)); • Imposing any terms or conditions on covered entities or pharmacies which differ from the terms or conditions applicable to other similarly situated pharmacies or entities on the basis that the entity or pharmacy is a covered entity or dispenses 340B drugs, including but not limited to certain terms and conditions described in the act. (Section 376.416.2(2)); • Interfering with an individual's choice to receive a 340B drug from a covered entity or pharmacy. (Section 376.416.2(3)); • Discriminating in reimbursement to a covered entity or pharmacy based on the determination or indication a drug is a 340B drug. (Section 376.416.2(4)); • Requiring a covered entity or pharmacy to identify a 340B drug sooner than 45 days after the point of sale of the drug. (Section 376.416.2(5)); • Refusing to contract with a covered entity or pharmacy for reasons other than those that apply equally to entities or pharmacies that are not covered entities or similarly situated pharmacies, or on the basis that the entity or pharmacy is a covered entity as described under federal law, or on the basis that the entity or pharmacy is described as a covered entity under provisions of federal law. (Section 376.416.2(6)); • Denying the covered entity the ability to purchase drugs at 340B program pricing by substituting a rebate discount. (Section 376.416.2(7)); • Refusing to cover drugs purchased under the 340B drug pricing program. (Section 376.416.2(8)); or • Requiring a covered entity or pharmacy to reverse, resubmit, or clarify a 340B-drug pricing claim after the initial adjudication unless these actions are in the normal course of pharmacy business and not related to the 340B drug pricing, except as required by federal law. (Section 376.416.2(9)). The Director of the Department of Commerce and Insurance shall impose a civil penalty on any health carrier or PBM violating certain provisions of the act, not to exceed $5,000 per violation per day. (Section 376.416.3). These provisions are identical to provisions in SB 13 (2025), and similar to provisions in SB 372 (2025), HB 784 (2025), HB 785 (2025), HB 943 (2025), the introduced SB 751 (2024), SCS/SBs 978 & 1035 (2024), SB 1213 (2024), HCS/HB 2267 (2024), HB 1977 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 426 (2023), HB 197 (2023), SB 921 (2022), HCS/HB 1677 (2022), SB 1129 (2022), and HB 2305 (2022). PRIOR AUTHORIZATION OF HEALTH CARE SERVICES (Sections 376.2100, 376.2102, 376.2104, 376.2106, and 376.2108) This act enacts provisions relating to prior authorization of health care services. Beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for a health care service unless the health carrier or utilization review entity determines that in the most recent evaluation period, as defined in the act, less than 90% of the prior authorization requests submitted by that provider for that health care service were approved or would have been approved. Also beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for any health care services unless the health carrier or utilization review entity has approved or would have approved less than 90% of all prior authorization requests submitted by that provider for health care services. Health carriers or utilization review entities may elect to have certain hospitals determine which of certain conditions, laid out in the act, the hospital will comply with in order to obtain a prior authorization exemption under the act. Exemptions from prior authorization under the act shall not apply to: pharmacy services, not to exceed the amount of $100,000; imaging services, not to exceed $100,000; cosmetic procedures that are not medically necessary; or investigative or experimental treatments. Maximum dollar amounts for these exceptions shall be adjusted annually for inflation as described in the act. The act further specifies certain prior authorization requests that shall not be included in making determinations under the act, specifies identification methods for the providers, includes provisions for the auditing and retraction of determinations under the act, allows for health carriers and utilization review entities to require providers to use an online portal to submit prior authorization requests, requires adverse determinations under the act to be reviewed by a clinical peer of the provider, and requires a grace period for patients who have received prior authorization for a 90-day supply of medication. Health carriers and utilization review entities shall notify providers within 25 days after a determination is made under the act, shall include in the notification certain information used in making the determination, shall establish an appeals process for the providers, and shall maintain an online prior authorization portal as described in the act. No health carrier or utilization review entity shall deny or reduce payment to a health care provider for a health care service for which the provider has prior authorization, except as described in the act. These provisions shall not apply to MO HealthNet services not provided through a managed care organization, or to providers who have not participated in a health benefit plan offered by the health carrier for at least one full evaluation period. These provisions are identical to provisions contained in SB 841 (2026), SB 13 (2025), HCS/SS#2/SB 79 (2025), HB 618 (2025), and similar to SB 897 (2026), HCS/HB 3010 (2026), HB 1675 (2026), SB 230 (2025), SB 751 (2024), SB 983 (2024), HB 1976 (2024), HB 2267 (2024), SB 576 (2023), and HB 1045 (2023). TAYLOR MIDDLETON
-
S 1882 — New York
Relates to certain farm wineries, farm breweries, farm distilleries, and farm cideries whose business includes agricultural tourism
Relates to certain farm wineries, farm breweries, farm distilleries, and farm cideries whose business includes agricultural tourism.
-
S 8613 — New York
Regulates an artificial person's contributions towards election activity and ballot-issue activity
Regulates an artificial person's contributions towards election and ballot-issue activity; provides limitations on the general powers of a corporation.
-
SB 136 — New Hampshire
establishing an uncompensated care assessment, fund, and committee within the department of insurance.
-
HB 525 — New Hampshire
transferring administration of the program for the deaf and hard of hearing and the board of licensure of interpreters for the deaf, deafblind, and hard of hearing to the office of professional licensure and certification.
-
HB 533 — New Hampshire
relative to the use of civilian employees in commercial truck inspections.
-
SB 185 — New Hampshire
relative to office of professional licensure and certification investigations.
-
SB 90 — New Hampshire
allowing high-density residential development on land zoned for commercial use.
-
HB 128 — New Hampshire
establishing a committee to study unemployment insurance.
-
SB 152 — New Hampshire
authorizing the sale of toll credits to fund a newly established noise barrier construction fund for the design and construction of noise barrier projects.
-
HB 728 — New Hampshire
authorizing video lottery terminals at charity gaming facilities and repealing historic horse racing licensing.
-
A 7448 — New York
Requires health care providers facilitate a screening for maternal depression within the first six weeks of a person giving birth
Requires maternal health care providers facilitate a screening for maternal depression, unless refused by the birth mother, within the first six weeks of birth and that such screening be covered by insurance.
-
S 6255 — New York
Relates to reimbursement for ambulance services
Relates to reimbursement for ambulance services; requires insurers to submit payments directly to ambulance providers who are in-network or, for out-of-network ambulance providers, requires the issuance of a joint check to the insured specifying both the insured and the ambulance provider as payees.
-
HR 3873 — Missouri
Informs the Governor that the 103rd General Assembly, Second Regular Session, is organized and ready for business
-
HR 3872 — Missouri
Informs the Senate that the House is duly convened and is in session ready for consideration of business
-
S 357 — New York
Relates to certified registered nurse anesthetists
Defines the practice of certified registered nurse anesthetist; requires collaboration with a licensed physician qualified to determine the need for anesthesia services; requires licensing; defines qualifications.
-
A 1172 — New York
Authorizes the dispensing of abortion medication
Authorizes the dispensing of abortion medication under certain conditions; requires insurance policies providing coverage for contraception to provide coverage for abortion medication.
-
A 7457 — New York
Authorizes the sale of non-alcoholic versions of alcoholic beverages by licensees
Authorizes the sale of non-alcoholic versions of alcoholic beverages by licensees and wholesalers; defines non-alcoholic versions of alcoholic beverages.
-
SB 15 — Kentucky
AN ACT relating to the protection of veterans' benefits.
Create a new section of KRS Chapter 40 to define terms; require any person seeking compensation for assisting with veterans' benefits to be accredited by the United States Department of Veterans Affairs; provide that the Act may be cited as the Veterans' Benefits Accreditation Act.
-
SCR 13 — Kentucky
A CONCURRENT RESOLUTION continuing the work of the Air Mobility and Aviation Economic Development Task Force by establishing the Aviation Economic Development Task Force.
Direct the Legislative Research Commission to establish the Aviation Economic Development Task Force and direct it to study and make recommendations; establish membership and meetings; direct the task force to submit its findings and recommendations to the Legislative Research Commission by December 1, 2026.
-
SB 21 — Kentucky
AN ACT relating to music therapy.
Create new sections of KRS Chapter 309 to define terms; establish a licensing board for professional music therapists; require 3 members of the board to have engaged in the practice or teaching of music therapy for at least 3 years; prohibit any persons not licensed by the board from holding himself or herself out as a licensed professional music therapist; authorize the board to promulgate administrative regulations; authorize the board to issue a license to practice music therapy; establish the process for license renewal, suspension, and revocation; establish fees for licensure; establish fee limitations; authorize the board to implement disciplinary actions; require a licensed professional music therapist to collaborate with a client's physician or other professional involved in the treatment of the client; require a licensed professional music therapist to collaborate with a client's mental health or substance use disorder professional involved in the treatment of the client; prohibit a licensed professional music therapist from replacing services provided by an audiologist or a speech-language pathologist; create the Kentucky Board of Licensure for Professional Music Therapists fund; establish a fine for violations; provide for initial board appointments.
-
B 26-0504 — District of Columbia
Modification Nos. M0014 and M0015 to Contract No. CW100401 with Wheeler Creek Estates Community Development Corporation Approval and Payment Authorization Emergency Act of 2025
-
B 26-0503 — District of Columbia
Contract No. CW114997 with Carahsoft Technology Corporation Approval and Payment Authorization Emergency Act of 2025
-
B 26-0505 — District of Columbia
Modification Nos. M0014 and M0015 to Contract No. CW100317 with Transitional Housing Corporation dba Housing Up Approval and Payment Authorization Emergency Act of 2025
-
HB 4493 — Michigan
Food: licensing; licensure exemptions; modify. Amends sec. 4105 of 2000 PA 92 (MCL 289.4105).
-
HB 4262 — Michigan
Consumer protection: other; attorney general investigations of the event online ticket sales act; provide for, and prescribe fines and remedies. Creates new act. TIE BAR WITH: SB 0158'25
-
HB 4282 — Michigan
Liquor: licenses; license to sell alcoholic liquor for consumption on the premises of certain locations; modify. Amends sec. 513 of 1998 PA 58 (MCL 436.1513). TIE BAR WITH: HB 4595'25